There have been 35 recent insider transactions recorded for Kalaris Therapeutics Inc (KLRS), including 22 buys and 2 sells. Total insider buying was valued at $28.85M and total insider selling at $21K.
Notable insiders with recent activity include Hagen Brett R, Feinsod Matthew, Oxtoby Andrew. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — KLRS
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-20 |
Hagen Brett R |
Chief Accounting Officer |
Informative Sell |
1,915 |
$6.72 |
$12.87K |
- |
| 2026-03-19 |
Feinsod Matthew |
Chief Medical Officer |
RSU Award |
135,000 |
$6.81 |
$919.35K |
135,000 |
| 2026-03-19 |
Oxtoby Andrew |
See Remarks |
RSU Award |
222,000 |
$6.81 |
$1.51M |
222,000 |
| 2026-03-19 |
Gall Matthew |
Chief Financial Officer |
RSU Award |
95,000 |
$6.81 |
$646.95K |
95,000 |
| 2026-03-19 |
Hagen Brett R |
Chief Accounting Officer |
RSU Award |
60,800 |
$6.81 |
$414.05K |
60,800 |
| 2025-12-22 |
Akkaraju Srinivas |
10 Percent Owner |
RSU Award |
1,500,000 |
$10.00 |
$15M |
1,500,000 |
| 2025-12-18 |
Akkaraju Srinivas |
10 Percent Owner |
Informative Buy |
479,847 |
$10.42 |
$5M |
1,979,847 |
| 2025-11-03 |
Gall Matthew |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-11-03 |
Gall Matthew |
Chief Financial Officer |
RSU Award |
235,000 |
$4.99 |
$1.17M |
235,000 |
| 2025-04-10 |
Patterson Leone D |
Director |
RSU Award |
18,000 |
$7.31 |
$131.58K |
18,000 |
| 2025-04-10 |
Akkaraju Srinivas |
10 Percent Owner |
RSU Award |
18,000 |
$7.31 |
$131.58K |
18,000 |
| 2025-04-10 |
Adamis Anthony P |
Director |
RSU Award |
18,000 |
$7.31 |
$131.58K |
18,000 |
| 2025-04-10 |
Patel Samir Chandrakant |
Director |
RSU Award |
18,000 |
$7.31 |
$131.58K |
18,000 |
| 2025-04-10 |
Jovan-embiricos Morana |
Director |
RSU Award |
18,000 |
$7.31 |
$131.58K |
18,000 |
| 2025-04-10 |
Hagen Brett R |
Chief Accounting Officer |
RSU Award |
50,262 |
$7.31 |
$367.42K |
50,262 |
| 2025-04-10 |
Feinsod Matthew |
Chief Medical Officer |
RSU Award |
70,551 |
$7.31 |
$515.73K |
70,551 |
| 2025-04-10 |
Ferrara Napoleone |
Director |
RSU Award |
18,000 |
$7.31 |
$131.58K |
18,000 |
| 2025-04-10 |
Oxtoby Andrew |
See Remarks |
RSU Award |
287,000 |
$7.31 |
$2.1M |
287,000 |
| 2025-04-03 |
Patterson Leone D |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-03-26 |
Hagen Brett R |
Chief Accounting Officer |
Informative Sell |
907 |
$8.97 |
$8.14K |
1,925 |
| 2025-03-18 |
Akkaraju Srinivas |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-03-18 |
Akkaraju Srinivas |
10 Percent Owner |
RSU Award |
11,444,503 |
- |
- |
11,444,503 |
| 2025-03-18 |
Adamis Anthony P |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-03-18 |
Adamis Anthony P |
Director |
RSU Award |
12,989 |
$0.55 |
$7.14K |
12,989 |
| 2025-03-18 |
Patel Samir Chandrakant |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-03-18 |
Patel Samir Chandrakant |
Director |
RSU Award |
100,800 |
- |
- |
100,800 |
| 2025-03-18 |
Dybbs Michael |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-03-18 |
Feinsod Matthew |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-03-18 |
Feinsod Matthew |
Chief Medical Officer |
RSU Award |
4,030 |
- |
- |
4,030 |
| 2025-03-18 |
Ferrara Napoleone |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-03-18 |
Ferrara Napoleone |
Director |
RSU Award |
504,000 |
- |
- |
504,000 |
| 2025-03-18 |
Oxtoby Andrew |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-03-18 |
Oxtoby Andrew |
See Remarks |
RSU Award |
476,611 |
$0.85 |
$405.12K |
476,611 |
| 2025-03-18 |
Samsara Biocapital Gp, Llc |
10 Percent Owner |
Unknown |
- |
- |
- |
11,448,081 |
| 2025-03-18 |
Akkaraju Srinivas |
10 Percent Owner |
Unknown |
- |
- |
- |
3,578 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
